Various studies have found that prostate-specific membrane antigen (PSMA), a metallopeptidase, is highly overexpressed on the surfaces of PCa cells2, making it a valuable research object in the field of molecular imaging and target therapy for PCa3–8. The gene discussed is FOLH1; the disease is posterior cortical atrophy.